Report Detail
Global (United States, European Union and China) Dendritic Cell Cancer Vaccine Market Research Report 2019-2025
- RnM3701649 |
- 27 August, 2019 |
- Global |
- 124 Pages |
- QYResearch |
- Pharma & Healthcare
Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells.
In 2019, the market size of Dendritic Cell Cancer Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dendritic Cell Cancer Vaccine.
This report studies the global market size of Dendritic Cell Cancer Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Dendritic Cell Cancer Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Medigene
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation (Dendreon)
Elios Therapeutics
Immunicum
Kiromic
Merck
Northwest Biotherapeutics
Glaxo Smith Kline
ImmunoCellular
Tella
Vaxil Bio
Medigene
Market Segment by Product Type
CreaVax
Sipuleucel-T (Provenge)
Others
Market Segment by Application
Pediatrics
Adults
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Dendritic Cell Cancer Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Dendritic Cell Cancer Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Dendritic Cell Cancer Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Dendritic Cell Cancer Vaccine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 CreaVax
- 1.3.3 Sipuleucel-T (Provenge)
- 1.3.4 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Dendritic Cell Cancer Vaccine Market Share by Application (2019-2025)
- 1.4.2 Pediatrics
- 1.4.3 Adults
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Dendritic Cell Cancer Vaccine Market Size
- 2.1.1 Global Dendritic Cell Cancer Vaccine Revenue 2014-2025
- 2.1.2 Global Dendritic Cell Cancer Vaccine Sales 2014-2025
- 2.2 Dendritic Cell Cancer Vaccine Growth Rate by Regions
- 2.2.1 Global Dendritic Cell Cancer Vaccine Sales by Regions 2014-2019
- 2.2.2 Global Dendritic Cell Cancer Vaccine Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Dendritic Cell Cancer Vaccine Sales by Manufacturers
- 3.1.1 Dendritic Cell Cancer Vaccine Sales by Manufacturers 2014-2019
- 3.1.2 Dendritic Cell Cancer Vaccine Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Dendritic Cell Cancer Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Dendritic Cell Cancer Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.3 Dendritic Cell Cancer Vaccine Price by Manufacturers
- 3.4 Key Manufacturers Dendritic Cell Cancer Vaccine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Dendritic Cell Cancer Vaccine Market
- 3.6 Key Manufacturers Dendritic Cell Cancer Vaccine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 CreaVax Sales and Revenue (2014-2019)
- 4.1.2 Sipuleucel-T (Provenge) Sales and Revenue (2014-2019)
- 4.1.3 Others Sales and Revenue (2014-2019)
- 4.2 Global Dendritic Cell Cancer Vaccine Sales Market Share by Type
- 4.3 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type
- 4.4 Dendritic Cell Cancer Vaccine Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Dendritic Cell Cancer Vaccine Sales by Application
6 United States
- 6.1 United States Dendritic Cell Cancer Vaccine Breakdown Data by Company
- 6.2 United States Dendritic Cell Cancer Vaccine Breakdown Data by Type
- 6.3 United States Dendritic Cell Cancer Vaccine Breakdown Data by Application
7 European Union
- 7.1 European Union Dendritic Cell Cancer Vaccine Breakdown Data by Company
- 7.2 European Union Dendritic Cell Cancer Vaccine Breakdown Data by Type
- 7.3 European Union Dendritic Cell Cancer Vaccine Breakdown Data by Application
8 China
- 8.1 China Dendritic Cell Cancer Vaccine Breakdown Data by Company
- 8.2 China Dendritic Cell Cancer Vaccine Breakdown Data by Type
- 8.3 China Dendritic Cell Cancer Vaccine Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Dendritic Cell Cancer Vaccine Breakdown Data by Company
- 9.2 Rest of World Dendritic Cell Cancer Vaccine Breakdown Data by Type
- 9.3 Rest of World Dendritic Cell Cancer Vaccine Breakdown Data by Application
- 9.4 Rest of World Dendritic Cell Cancer Vaccine Breakdown Data by Countries
- 9.4.1 Rest of World Dendritic Cell Cancer Vaccine Sales by Countries
- 9.4.2 Rest of World Dendritic Cell Cancer Vaccine Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Medigene
- 10.1.1 Medigene Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
- 10.1.4 Dendritic Cell Cancer Vaccine Product Introduction
- 10.1.5 Medigene Recent Development
- 10.2 Activarti
- 10.2.1 Activarti Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
- 10.2.4 Dendritic Cell Cancer Vaccine Product Introduction
- 10.2.5 Activarti Recent Development
- 10.3 Argos Therapeutics
- 10.3.1 Argos Therapeutics Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
- 10.3.4 Dendritic Cell Cancer Vaccine Product Introduction
- 10.3.5 Argos Therapeutics Recent Development
- 10.4 Batavia Bioservices
- 10.4.1 Batavia Bioservices Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
- 10.4.4 Dendritic Cell Cancer Vaccine Product Introduction
- 10.4.5 Batavia Bioservices Recent Development
- 10.5 Bellicum Pharmaceuticals
- 10.5.1 Bellicum Pharmaceuticals Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
- 10.5.4 Dendritic Cell Cancer Vaccine Product Introduction
- 10.5.5 Bellicum Pharmaceuticals Recent Development
- 10.6 Creagene
- 10.6.1 Creagene Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
- 10.6.4 Dendritic Cell Cancer Vaccine Product Introduction
- 10.6.5 Creagene Recent Development
- 10.7 DanDrit Biotech
- 10.7.1 DanDrit Biotech Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
- 10.7.4 Dendritic Cell Cancer Vaccine Product Introduction
- 10.7.5 DanDrit Biotech Recent Development
- 10.8 DCPrime
- 10.8.1 DCPrime Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
- 10.8.4 Dendritic Cell Cancer Vaccine Product Introduction
- 10.8.5 DCPrime Recent Development
- 10.9 Sanpower Corporation (Dendreon)
- 10.9.1 Sanpower Corporation (Dendreon) Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
- 10.9.4 Dendritic Cell Cancer Vaccine Product Introduction
- 10.9.5 Sanpower Corporation (Dendreon) Recent Development
- 10.10 Elios Therapeutics
- 10.10.1 Elios Therapeutics Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
- 10.10.4 Dendritic Cell Cancer Vaccine Product Introduction
- 10.10.5 Elios Therapeutics Recent Development
- 10.11 Immunicum
- 10.12 Kiromic
- 10.13 Merck
- 10.14 Northwest Biotherapeutics
- 10.15 Glaxo Smith Kline
- 10.16 ImmunoCellular
- 10.17 Tella
- 10.18 Vaxil Bio
- 10.19 Medigene
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Dendritic Cell Cancer Vaccine Sales Channels
- 11.2.2 Dendritic Cell Cancer Vaccine Distributors
- 11.3 Dendritic Cell Cancer Vaccine Customers
12 Market Forecast
- 12.1 Global Dendritic Cell Cancer Vaccine Sales and Revenue Forecast 2019-2025
- 12.2 Global Dendritic Cell Cancer Vaccine Sales Forecast by Type
- 12.3 Global Dendritic Cell Cancer Vaccine Sales Forecast by Application
- 12.4 Dendritic Cell Cancer Vaccine Forecast by Regions
- 12.4.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Regions 2019-2025
- 12.4.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Dendritic Cell Cancer Vaccine. Industry analysis & Market Report on Dendritic Cell Cancer Vaccine is a syndicated market report, published as Global (United States, European Union and China) Dendritic Cell Cancer Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Dendritic Cell Cancer Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
